ENTITY
Amgen Inc

Amgen Inc (AMGN US)

180
Analysis
Health CareUnited States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
bullishAmgen Inc
07 Nov 2024 14:00

Amgen Inc.: What Is The Recent Pipeline Development & Expected Product Launches? - Major Drivers

Amgen's third quarter 2024 financial results underscore the biopharmaceutical company's robust position in the market, with notable performance in...

Logo
121 Views
Share
bullishAmgen Inc
16 Aug 2024 15:00

Amgen Inc.: Expansion of MariTide and Pipeline Advancement! - Major Drivers

Amgen's second quarter 2024 financial results signify a substantial 20% year-over-year increase reaching $8.4 billion in revenue, representing a...

Logo
319 Views
Share
bullishAmgen Inc
16 May 2024 02:00

Amgen Inc.: Will The Increased Spending on Research and Development (R&D) Pay Off? - Major Drivers

Amgen Inc. witnessed strong growth in the Q1 of 2024 with total revenue increasing by 22% YoY. This was largely driven by strong volume growth,...

Logo
185 Views
Share
bullishAmgen Inc
16 Feb 2024 05:00

Amgen Inc: An Analysis Of The Pipeline Progress and Development! - Major Drivers

Amgen's Fourth Quarter 2023 Financial Results Conference Call highlighted several strategic moves and positive outcomes for the biotechnology...

Logo
214 Views
Share
17 Nov 2024 09:29

Who Are Leading the Charge in the RNAissance of Medicine

RNA therapeutics: We analyze the field and spotlight top players driving this precision medicine, for tackling rare diseases with innovative solutions

Logo
243 Views
Share
x